semaglutide and other medications & Tirzepatide: Can You Combine Them? What's New in Obesity Treatment?
Description
How PlexusDx Supports a More Personalized Approach Genetic predispositions in GLP-1 receptor signaling, GIPR pathways, and metabolic genes (such as FTO and MC4R variants) may provide context for why some patients experience better appetite suppression or weight loss with specific GLP-1 formulations
:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
The FTO rs9939609 variant relates to baseline metabolic rate and fat storage tendency
Well be here for you every step of the way on your weight loss journey
Vol NCHS Date Brief No
Healthy Fats That Support GLP-1 Release: Not all fats are harmful
